Novel 6-substituted 2-aminotetralins with potent and selective affinity for the dopamine D3 receptor

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 4, 1996, Pages 403-408

  Murray, P J ^a,b   Helden, R M ^a   Johnson, M R ^a   Robertson, G M ^a   Scopes, D I C ^a   Stokes, M ^a   Wadman, S ^a   Whitehead, J W F ^a   Hayes, A G ^a   Kilpatrick, G J ^a   Large, C ^a   Stubbs, C M ^a   Turpin, M P ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOTETRALIN DERIVATIVE; 2 DIPROPYLAMINO 1,2,3,4 TETRAHYDRO 6 (4 METHOXYPHENYLSULFONYLMETHYL)NAPHTHALENE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; HUMAN; MOUSE; NONHUMAN; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 17144437584     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00043-1     Document Type: Article

References (9)

1. For recent reviews on novel dopamine receptor subtypes see: Civelli, O.; Bunzow, J.R.; Grandy, D.K.; Zhou, Q-Y.; Van Tol, H.H.M. Eur.J.Pharmacol. 1991, 207, 277. Sibley, D.R.; Monsma, F.J. TIPS 1992, 13, 61.
2. For recent reviews on novel dopamine receptor subtypes see: Civelli, O.; Bunzow, J.R.; Grandy, D.K.; Zhou, Q-Y.; Van Tol, H.H.M. Eur.J.Pharmacol. 1991, 207, 277. Sibley, D.R.; Monsma, F.J. TIPS 1992, 13, 61.
3. Sokoloff, P.; Giros, B.; Martres, M-P.; Bouthenet, M-L.; Schwartz, J-C. Nature 1990, 347, 146.
4. Sokoloff, P.; Andrieux, M.; Besancon, R.; Pilon, C.;Martres, M-P.; Giros, B.; Schwartz, J-C. EurJ.Pharmacol. 1992, 225, 331.
5. Jenner, P.; Marsden, C.D. Drugs in Central Nervous System Disorders; Horwell, D.C., Ed.; Marcel Dekker: New York 1985; pp.149-262.
6. Sokoloff, P.; Martres, M-P.; Giros, B.; Bouthenet, M-L.; Schwartz, J-C. Biochem.Pharmacol. 1992, 43, 659. Schwartz, J-C.; Levesque, D.; Martres, M-P.; Sokoloff, P. Clin.Neuropharmacol. 1993, 16, 295.
7. Sokoloff, P.; Martres, M-P.; Giros, B.; Bouthenet, M-L.; Schwartz, J-C. Biochem.Pharmacol. 1992, 43, 659. Schwartz, J-C.; Levesque, D.; Martres, M-P.; Sokoloff, P. Clin.Neuropharmacol. 1993, 16, 295.
8. Bull, D.R.; Patij, P.; Sheehan, M.J.; Stamford, J.A.; Kruk, Z.L.; Humphrey, P.P.A. J. Neurosci. Methods 1990, 32, 37.
9. All new compounds exhibited satisfactory spectral and elemental analysis data.